Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT06688396

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
  • Mayo Clinic Registry lists this organization as a collaborator
Registry
  • NCT NCT06688396
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06688396. Allocation not applicable; no masking; primary purpose screening. Start 2024-12-04 (actual); primary completion 2026-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
Acronym
DCM-DETECT
Condition
Dilated Cardiomyopathy
Condition
Heart Failure
Condition
Heart Disease
Intervention (Device)
Mobile 6L AI-EKG Screening
Lead sponsor
Lancaster General Hospital (class: other)
Collaborator
Mayo Clinic (class: other)

Record details

Record id
cardio:ct-nct06688396
Content hash
dbe9c97360c4274a241a77e6a6e0613ef419d3ac73cf5a7c014784649c63fac7